U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059923) titled 'Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)' on July 01.
Brief Summary: CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
Study Start Date: July, 2025
Study Type: OBSERVATIONAL
Condition:
Lung Cancer (Diagnosis)
Recruitment Status: RECRUITING
Sponsor: Wuhan Union Hospital, China
P...